Nucor Corp.’s (NUE) shares rose 1.9% after the company reported first-quarter 2025 adjusted earnings per share of $0.77, surpassing the Zacks Consensus Estimate of $0.68. Shares of Regeneron Pharmaceuticals Inc. (REGN) plunged 6.9% after posting first-quarter 2025 adjusted earnings per share of $8.22, missing the Zacks Consensus Estimate of $8.43. PayPal Holdings Inc.’s (PYPL) shares gained 2.1% after the company posted first-quarter 2025 adjusted earnings per share of $1.33, outpacing the Zacks Consensus Estimate of $1.15. Shares of Pfizer Inc. (PFE) advanced 3.2% after reporting first-quarter 2025 adjusted earnings per share of $0.92, beating the Zacks Consensus Estimate of $0.64. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Regeneron Pharmaceuticals, Inc. (REGN):Free Stock Analysis Report Pfizer Inc. (PFE):Free Stock Analysis Report Nucor Corporation (NUE):Free Stock Analysis Report PayPal Holdings, Inc. (PYPL):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Company News for Apr 30, 2025
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...